Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor - Clark, R V; Hermann, D J; Cunningham, G R; Wilson, T H; Morrill, B B; Hobbs, S (J Clin Endocrinol Metab, 2004)